Anticalculus effect of a triclosan mouthwash containing phytate: A double-blind, randomized, three-period crossover trial

Journal of Periodontal Research

Volumn 44, Issue 5, 2009, Pages 616-621

  Grases, F ^a   Perello J ^a   Sanchis, P ^a   Isern, B ^a   Prieto, R M ^a   Costa Bauza A ^a   Santiago, C ^b   Ferragut, M L ^b   Frontera, G ^c  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b Dental Clinic Periodent   (Spain)

^c HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Clinical trial; Dental calculi; Phytate; Zinc

Indexed keywords

CALCIUM; CALCIUM PHOSPHATE; HYDROXYAPATITE; MAGNESIUM; MOUTHWASH; PHOSPHORUS; PHYTIC ACID; PLACEBO; TOPICAL ANTIINFECTIVE AGENT; TRICLOSAN; ZINC;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CRYSTALLIZATION; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; FEMALE; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TOOTH CALCULUS; TOOTH PLAQUE;

ADOLESCENT; ADULT; AGED; ANTI-INFECTIVE AGENTS, LOCAL; CALCIUM; CALCIUM PHOSPHATES; CROSS-OVER STUDIES; CRYSTALLIZATION; DENTAL CALCULUS; DENTAL PLAQUE; DOUBLE-BLIND METHOD; DURAPATITE; FEMALE; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; MOUTHWASHES; PHOSPHORUS; PHYTIC ACID; PLACEBOS; TRICLOSAN; YOUNG ADULT; ZINC;

EID: 69249123811     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2008.01168.x     Document Type: Article

References (24)

1. Jin Y, Yip HK. Supragingival calculus: formation and control. Crit Rev Oral Biol Med 2002 13 : 426 441.
2. Grases F, Söhnel O, Costa-Bauzá A, Ramis M, Wang Z. Study on concretions developer around urinary catheters and mechanisms of renal calculi development. Nephron 2001 88 : 320 328.
3. Grases F, Costa-Bauzá A, García-Ferragut L. Biopathological crystallization: a general view about the mechanisms of renal stone formation. Adv Colloid Interface Sci 1998 74 : 169 194.
4. Chikte UM, Rudolph MJ, Reinach SG. Anti-calculus effects of dentifrice containing pyrophosphate compared with control. Clin Prev Dent 1992 14 : 29 33.
5. Kohut BE, Yu D, Hovliaras-Delozier C. Anticalculus efficacy o fan essential oil dentifrice containing 1.3% pyrophosphate ion. J Clin Dent 1997 8 : 138 141.
6. White DJ, Gerlach RW. Anticalculus effects of a novel, dual-phase polypyrophosphate dentifrice: chemical basis, mechanism, and clinical response. J Contemp Dent Pract 2000 1 : 1 12.
7. Porciani PF, Grandini S, Sapio S. Anticalculus efficacy of a chewing gum with polyphosphates in a twelve-week single-blind trial. J Clin Dent 2003 14 : 45 47. (Pubitemid 38209830)
8. Adams D. Calculus inhibition agents: a review of recent clinical trials. Adv Dental Res 1995 9 : 410 418.
9. Stookey GK, Jackson RJ, Beiswanger BB, Stookey KR. Clinical efficacy of chemicals for calculus prevention. In : Ten Cate J, ed. Recent Advances in the Study of Dental Calculus. Oxford : IRL Press, 1989 : 235 238.
10. Volpe AR, Petrone ME, Davies R. A review of calculus clinical efficacy studies. J Clin Dent 1992 4 : 71 81.
11. White DJ. Dental calculus: recent insights into occurrence, formation, prevention, removal and oral health effects of supragingival and subgingival deposits. Eur J Oral Sci 1997 105 : 508 522.
12. Fleisch H, Bisaz S. Isolation from urine of pyrophosphate, a calcification inhibitor. Am J Physiol 1962 203 : 671 675.
13. Fleisch H, Neuman WF. Mechanism of calcification: role of collagen, polyphosphates, and phosphatases. Am J Physiol 1961 200 : 1296 1300.
14. Mühlemann HR, Bowles D, Schatt A, Bernimoulin JP. Effect of diphosphonate on human supragingival calculus. Helv Odontol Acta 1970 14 : 31 33.
15. Sturzenberger OP, Swancar JR, Reiter G. Reduction of dental calculus in humans through the use of a dentifrice containing a crystal-growth inhibitor. J Periodontol 1971 42 : 416 419.
16. 6 levels in tissues and biological fluids depending on dietary phytate. J Nutr Biochem 2001 12 : 595 601.
17. 6 or phytate) in humans. Biofactors 2001 15 : 53 61.
18. Grases F, Ramis M, Costa-Bauzá A. Effects of phytate and pyrophosphate on brushite and hydroxyapatite crystallization. Urol Res 2000 28 : 136 140.
19. Grases F, Prieto RM, Simonet BM, March JG. Phytate prevents tissue calcifications in female rats. Biofactors 2000 11 : 171 177.
20. Grases F, Perelló J, Prieto RM, Simonet BM, Torres JJ. Dietary myo-inositol hexaphosphate prevents dystrophic calcifications in soft tissues: a pilot study in Wistar rats. Life Sci 2004 75 : 11 19.
21. Grases F, Genestar C, Millán A. The influence of some metallic ions and their complexes on the kinetics of crystal growth of calcium oxalate. J Cryst Growth 1989 94 : 507 512.
22. Senn S. Cross-Over Trials in Clinical Research, 2nd edn. London, England : John Wiley & Sons, 2002.
23. Grases F, Sanchis P, Perelló J et al. Phytate (Myo-inositol hexakisphosphate) inhibits cardiovascular calcifications in rats. Front Biosci 2006 11 : 136 142.
24. Grases F, Sanchis P, Perelló J et al. Effect of crystallization inhibitors on vascular calcifications induced by vitamin D: a pilot study in Sprague-Dawley rats. Circulation J 2007 71 : 1152 1156.